NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 383 filers reported holding NEKTAR THERAPEUTICS in Q2 2018. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $199,000 | -32.3% | 11,600 | -21.1% | 0.00% | – |
Q1 2021 | $294,000 | -74.6% | 14,700 | -78.4% | 0.00% | -100.0% |
Q4 2020 | $1,159,000 | +2.5% | 68,193 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $1,131,000 | -56.5% | 68,193 | -39.2% | 0.00% | -50.0% |
Q2 2020 | $2,599,000 | -10.5% | 112,236 | -31.0% | 0.00% | -33.3% |
Q1 2020 | $2,905,000 | +53.0% | 162,760 | +85.0% | 0.01% | +100.0% |
Q4 2019 | $1,899,000 | -77.0% | 87,960 | -80.6% | 0.00% | -66.7% |
Q3 2019 | $8,274,000 | +2.9% | 454,242 | +101.0% | 0.01% | -47.1% |
Q2 2019 | $8,042,000 | +183.6% | 226,021 | +167.8% | 0.02% | +183.3% |
Q1 2019 | $2,836,000 | +14.3% | 84,400 | +11.8% | 0.01% | 0.0% |
Q4 2018 | $2,482,000 | -86.6% | 75,500 | -75.2% | 0.01% | -84.6% |
Q3 2018 | $18,560,000 | -23.4% | 304,462 | -38.6% | 0.04% | -32.8% |
Q2 2018 | $24,223,000 | -53.4% | 496,061 | +1.5% | 0.06% | -54.7% |
Q1 2018 | $51,950,000 | +3453.4% | 488,894 | +702.8% | 0.13% | +3100.0% |
Q3 2017 | $1,462,000 | -27.0% | 60,900 | -39.5% | 0.00% | -33.3% |
Q2 2017 | $2,002,000 | -10.6% | 100,700 | +5.6% | 0.01% | -14.3% |
Q1 2017 | $2,239,000 | +23.4% | 95,400 | -35.5% | 0.01% | 0.0% |
Q4 2016 | $1,815,000 | – | 147,900 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
TOBAM | 640,547 | $21,522,000 | 1.09% |
Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |